or
Bookmark and Share
Pharmacologically active ketones and use
   
Document Number
US Patent 4791136
Issued Date
December 13, 1988
Link
Inventors
Map
Abstract
Use of compounds of formula (I) ##STR1## to provide a more effective delivery of oxygen to the tissues of a mammalian, including human, recipient. In vivo applications include the relief or amelioration of conditions wherein there is tissue hypoxia; in vitro the compounds are of use in the storage of mammalian, including human, red blood cells to maintain their oxygen-delivery capacity and prolong their useful storage life. Also provided is a sterile, sealed vessel containing an anticoagulant, a non-toxic amount of a compound of formula (I) and optionally mammalian, in particular human, red blood cells.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
12
Comments:
no comments yet
Owner
Burroughs Wellcome Co. (Research Triangle Park, NC)
Published
December 13, 1988
Application Number
06/891,768
Filed
July 30, 1986
US Classification
514/456  
Int'l Classification
A61K   31/35   (20060101)  
Assistant Examiner
Attorney/Law Firm
Parent Case
This is a division of application Ser. No. 662,709 filed Oct. 19, 1984 now U.S. Pat. No. 4,626,431.
Priority Data
Oct 25, 1983 [GB] 8328495
USPTO Field of Search
514/456  
Related Patents
6559133 - Use of flavone 8-acetic acid in vascular and cardiovascular interventions and acute coronary syndromes

A method for treatment of a vascular or cardiovascular condition or acute coronary syndromes comprises administering an effective amount of a flavone 8-carboxylic acid to a mammal suffering from a vascular or cardiovascular condition or acute coronary syndromes. The flavone 8-carboxylic acid is typically flavone 8-acetic acid. The flavone 8-carboxylic acid can be administered alone or in combination with another agent such as a thrombolytic agent, an antithrombotic agent, an anticoagulant, or an antiplatelet agent. The invention also includes pharmaceutical compositions formulated for the treatment of a vascular or cardiovascular condition or acute coronary syndromes.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us